2 unknown. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Unknown 2 |
Follow Myxofibrosarcoma: new trials by email Literature Review of Myxofibrosarcoma trials Research Report on Myxofibrosarcoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ENVASARC: Envafolimab And Envafolimab With Ipilimumab In Patients With Undifferentiated Pleomorphic Sarcoma Or Myxofibrosarcoma Envafolimab, Ipilimumab - Undifferentiated Pleomorphic Sarcoma, Myxofibrosarcoma | Phase 2 | Unknown | Tracon Pharmaceuticals Inc. | 207 | 2020-12-09 | 2024-05-17 |
| Hypofractionated Radiotherapy With Sequential Chemotherapy in Marginally Resectable Soft Tissue Sarcomas of Extremities or Trunk Wall Sequential chemotherapy - 3 courses of AI, Hypofractionated radiotherapy - Sarcoma, Fibrosarcoma | Phase 2 | Unknown | Maria Sklodowska-Curie National Research Institute of Oncology | 46 | 2017-02-11 | 2021-01-22 |
Dermatofibrosarcoma (2) · Histiocytoma, Malignant Fibrous (2) · Sarcoma (2) · Fibrosarcoma (1) · Histiocytic Sarcoma (1) · Leiomyosarcoma (1) · Liposarcoma (1) · Liposarcoma, Myxoid (1) · Lymphangiosarcoma (1) · Myosarcoma (1) · Neurofibrosarcoma (1) · Sarcoma, Synovial (1)
Histiocytoma (2) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Neoplasms, Connective Tissue (2) · Neoplasms, Connective and Soft Tissue (2) · Neoplasms, Fibrous Tissue (2) · Fibrosarcoma (1) · Hemic and Lymphatic Diseases (1) · Histiocytic Disorders, Malignant (1) · Histiocytosis (1) · Lymphatic Diseases (1) · Neoplasm, Lymphatic Tissue (1) · Neoplasms, Adipose Tissue (1) · Neoplasms, Muscle Tissue (1) · Neoplasms, Nerve Tissue (1)
Ipilimumab (1) · Radiation Dose Hypofractionation (1) · envafolimab (1)
Maria Sklodowska-Curie National Research Institute of Oncology (1) · Tracon Pharmaceuticals Inc. (1)
Poland (1) · United Kingdom (1) · United States (1)